GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | +100.0% | 300 | 0.0% | 0.01% | +116.7% |
| Q2 2022 | $10,000 | -28.6% | 300 | -38.5% | 0.01% | -14.3% |
| Q4 2021 | $14,000 | +16.7% | 488 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $12,000 | -29.4% | 488 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $17,000 | -51.4% | 488 | -43.5% | 0.01% | -55.0% |
| Q1 2021 | $35,000 | -12.5% | 863 | -6.7% | 0.02% | -28.6% |
| Q4 2020 | $40,000 | -31.0% | 925 | 0.0% | 0.03% | -52.5% |
| Q2 2020 | $58,000 | +23.4% | 925 | 0.0% | 0.06% | -1.7% |
| Q1 2020 | $47,000 | +4.4% | 925 | 0.0% | 0.06% | +106.9% |
| Q3 2019 | $45,000 | +36.4% | 925 | +48.0% | 0.03% | +31.8% |
| Q2 2019 | $33,000 | 0.0% | 625 | 0.0% | 0.02% | -12.0% |
| Q1 2019 | $33,000 | +32.0% | 625 | -5.0% | 0.02% | +108.3% |
| Q3 2018 | $25,000 | – | 658 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |